Ocular Therapeutix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 267
- Market Cap
- -
- Website
- http://www.ocutx.com
Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2016-12-14
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT02312544
- Locations
- 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
ReSure Sealant Post Approval Study
Completed
- Conditions
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 626
- Registration Number
- NCT02310815
OTX-14-002: Device Exposure Registry
Withdrawn
- Conditions
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Registration Number
- NCT02309736
OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2019-09-26
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 241
- Registration Number
- NCT02089113
OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-02-14
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 68
- Registration Number
- NCT02062905
Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 247
- Registration Number
- NCT02034019
- Locations
- 🇺🇸
Texan Eye / Keystone Research, Ltd., Austin, Texas, United States
Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT01845038
- Locations
- 🇿🇦
Umhlanga Hospital Medical Centre, Durban, South Africa
Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug
- First Posted Date
- 2013-02-27
- Last Posted Date
- 2016-02-11
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01800175
Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-08-16
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01666210
- Locations
- 🇺🇸
Chicago Cornea Consultants, Ltd., Hoffman Estates, Illinois, United States
ReSure Sealant Pivotal Study
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Ocular Therapeutix, Inc.
- Target Recruit Count
- 488
- Registration Number
- NCT01498224
- Locations
- 🇺🇸
Levenson Eye Associates, Jacksonville, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath